We found three positive (VEGF, beta-Catenin and C-C motif chemokine 22 (CCL22)) and two negative (LIF, sIL10RB) associations between five prediagnostic serum cytokines and the subsequent risk of glioma. Here, CTNNB1 is linked to central nervous system cancer.